Latest Regulatory Changes News

Avecho Biotechnology has bolstered its cash reserves by $1.9 million through the exercise of listed options, positioning the company for a pivotal Phase III interim analysis readout for its insomnia treatment.

EDU Holdings delivered a transformational FY25 with nearly doubled revenue and a debt-free balance sheet, driven by strong growth in its higher education arm Ikon. The company started FY26 on a solid footing despite regulatory headwinds.

Westpac Banking Corporation posted a statutory net profit of AUD 3.414 billion for the half year ended March 2026, marking a 3% increase on the prior corresponding period despite a 5% decline from the previous half. The bank maintained a strong capital position and declared a fully franked interim dividend of 77 cents per share.

Critical Resources Limited (ASX:CRR) has initiated a pro-rata entitlement offer of Loyalty Options priced at $0.001 each, aiming to raise $319,410 and potentially $2.56 million upon exercise. The offer underscores significant dilution and operational risks amid ongoing exploration and legal challenges.

Kina Securities has successfully closed an oversubscribed PGK 235 million subordinated bond, set to list on the PNGX Debt Market on 6 May 2026, offering a fixed 7.55% coupon over ten years.

Light & Wonder (ASX:LNW) posted modest revenue growth in 2025, driven by Gaming and iGaming segments, while SciPlay revenue dipped slightly. The company completed its Grover acquisition, settled a $128 million IP dispute with Aristocrat, and transitioned to a sole ASX listing.

Orbital Corporation advances its UAV engine production and hybrid propulsion technology while managing a $0.5 million net cash outflow in Q1 2026, supported by a $43 million business pipeline and new international contracts.

Nickel Industries delivered its strongest quarterly earnings since late 2023, propelled by a 222% jump in ore sales and significant margin improvements across its nickel processing operations amid favourable regulatory changes and rising nickel prices.

Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Ainsworth Game Technology’s FY25 results reveal a mixed bag: a 9% dip in underlying profit to $21.1 million, a hefty $43.1 million goodwill impairment tied to North America, and a strategic pivot with a new acting CEO. Strong Asia Pacific growth and new product launches contrast with margin pressures and a shrinking cash position.

Newmont Corporation delivered a standout first quarter in 2026, reporting $3.3 billion net income and $3.1 billion free cash flow, while authorising an additional $6 billion share repurchase program after completing the previous one.